Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?

被引：0
|
作者：
Gelanew, Tesfaye [1 ]
Wassie, Liya [1 ]
Mulu, Andargachew [1 ]
Wondwossen, Liya [2 ]
Abebe, Markos [1 ]
Mihret, Adane [1 ]
Abdissa, Alemseged [1 ]
机构：
[1] Armauer Hansen Res Inst, Addis Ababa, Ethiopia
[2] Fed Minist Hlth, Addis Ababa, Ethiopia
来源：
FRONTIERS IN PUBLIC HEALTH | 2023年 / 10卷
关键词：
COVID-19; dose; Ethiopia; heterologous; homologous; vaccine; intramuscular; intradermal; WILLINGNESS;
D O I：
10.3389/fpubh.2022.1046546
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页数：7
相关论文
共 50 条
  • [31] Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
    Banerjee, K.
    Cu, Y.
    Sun, Y.
    Hartog, K.
    Dey, A.
    Brito, L.
    Verma, A.
    Nandi, A.
    Sarkar, P.
    Valiante, N. M.
    Geall, A. J.
    Barnett, S. W.
    Otten, G. R.
    [J]. RETROVIROLOGY, 2012, 9
  • [32] Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates
    Luo, Shengxue
    Zhang, Panli
    Liu, Bochao
    Yang, Chan
    Liang, Chaolan
    Wang, Qi
    Zhang, Ling
    Tang, Xi
    Li, Jinfeng
    Hou, Shuiping
    Zeng, Jinfeng
    Fu, Yongshui
    Allain, Jean-Pierre
    Li, Tingting
    Zhang, Yuming
    Li, Chengyao
    [J]. EMERGING MICROBES & INFECTIONS, 2021, 10 (01) : 1002 - 1015
  • [33] Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
    Meurisse, Marjan
    Catteau, Lucy
    van Loenhout, Joris A. F.
    Braeye, Toon
    De Mot, Laurane
    Serrien, Ben
    Blot, Koen
    Cauet, Emilie
    Van Oyen, Herman
    Cuypers, Lize
    Robert, Annie
    Van Goethem, Nina
    [J]. VACCINES, 2023, 11 (02)
  • [34] Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
    Kleebayoon, Amnuay
    Wiwanitkit, Viroj
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (05) : 432 - 433
  • [35] Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA COVID-19 vaccines in immunocompromised patients
    Chu, Chang
    Schoenbrunn, Anne
    Fischer, Dorothea
    Liu, Yvonne
    Hocher, Johann-Georg
    Weinerth, Jutta
    Klemm, Kristin
    von Baehr, Volker
    Kraemer, Bernhard K.
    Elitok, Saban
    Hocher, Berthold
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [36] Heterologous prime-boost vaccination with a peptidebased vaccine and viral vector improves antitumor therapy
    Alfei, F.
    Belnoue, E.
    Rossi, M.
    Derouazi, M.
    Devy-Dimanche, L.
    Santiago-Raber, M. L.
    [J]. SWISS MEDICAL WEEKLY, 2023, 153 : 10S - 10S
  • [37] Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines
    Hu, Zhidong
    Jiang, Weimin
    Gu, Ling
    Qiao, Dan
    Shu, Tsugumine
    Lowrie, Douglas B.
    Lu, Shui-Hua
    Fan, Xiao-Yong
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2019, 97 (12): : 1685 - 1694
  • [38] Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
    Lv, Jingjing
    Wu, Hui
    Xu, Junjie
    Liu, Jiaye
    [J]. INFECTIOUS DISEASES OF POVERTY, 2022, 11 (01)
  • [39] A prime-boost vaccination of mice with heterologous H5N1 strains
    Ikeno, Daisuke
    Kimachi, Kazuhiko
    Kudo, Yasuhiro
    Goto, Shuro
    Itamura, Shigeyuki
    Odagiri, Takato
    Tashiro, Masato
    Kino, Yoichiro
    [J]. VACCINE, 2009, 27 (23) : 3121 - 3125
  • [40] Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
    Jingjing Lv
    Hui Wu
    Junjie Xu
    Jiaye Liu
    [J]. Infectious Diseases of Poverty, 11
12345